Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

INH A21

Drug Profile

INH A21

Alternative Names: INH-A00021; INHA-21; Veronate

Latest Information Update: 11 Jul 2006

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Inhibitex
  • Class Immunoglobulins; Immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Staphylococcal infections; Nosocomial infections; Neonatal infections
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Neonatal infections; Nosocomial infections; Staphylococcal infections

Most Recent Events

  • 11 Jul 2006 Review of final results from a phase III clinical trial in very low birth weight infants for the prevention of staphylococcal infections have been added to the Bacterial Infections therapeutic trials section and to the overview section
  • 10 Apr 2006 Final results from a phase II clinical trial in very low birth weight infants for the prevention of staphylococcal infections have been added to the adverse events and Bacterial Infections therapeutic trials sections
  • 03 Apr 2006 Interim results from a phase III clinical trial in premature infants for the prevention of nosocomial bloodstream infections due to S. aureus have been added to the adverse events and Bacterial Infections therapeutic trials sections
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top